Molecular BiologybioRxivPreprint
Drug development of an affinity enhanced, broadly neutralizing heavy chain-only antibody that restricts SARS-CoV-2 in rodents
Bert Schepens, Loes van Schie, Wim Nerinckx…·Xavier Saelens
The paper describes the development of a broadly neutralizing antibody, XVR011, effective against SARS-CoV-2 and its variants in animal models.